Albumin Peptide | ʻO ka meaʻai palekana, kūkulu i kahi laina pale ikaika no ke olakino kino!
Ma ke kahua o ke olakino maʻamau, i hoʻopilikia ʻia e ka meaʻai maikaʻi ʻole, ka hoʻemi ʻana i ka hoʻomaʻamaʻa ʻana, ka noho ʻana i ka pō a me nā kumu olakino ʻē aʻe, ʻaʻole i emi ke koi aupuni no ke olakino Yuneng, a ua loaʻa mālie nā albumin peptides i ka mākeke i nā makahiki i hala.
Nā manawa hou no ke olakino
E hoʻoikaika i ka ikehu a me ka pale pono'ī
I loko o ka nohona o kēia mau lā, hoʻomau ka hoʻonui ʻana i ka ʻike olakino olakino. Hōʻike ka ʻikepili i ka "2023 National Health Insight Report - Family Health" i waena o nā pono meaʻai o ka poʻe, ʻo ka pono no ka "hoʻonui i ka palekana" hiki i ka 79%, e lilo ana i ka hapa kiʻekiʻe o nā pono meaʻai. [1]
Puna kiʻi: Dr. Lilac's "2023 National Health Insight Report-Family Health"
I nā makahiki i hala iho nei, ua nui ka nānā ʻana o nā kānaka i ke olakino. Ua wānana pū ka US NBJ i ka makahiki 2025, e piʻi ana ke kūʻai aku o ka mākeke meaʻai olakino olakino i ka 25 biliona kālā ʻAmelika.
Albumin peptide
E hoʻokō i nā ʻano meaʻai olakino olakino
Me ka ulu ʻana o nā pono olakino e pili ana, ua lilo pū ka albumin peptides i mea waiwai nui o ka hopohopo i ke kula olakino.
ʻO ka albumin peptide kahi bioactive enzymatically hydrolyzed ovalbumin liʻiliʻi mole oligopeptide ikaika i unuhi ʻia mai ka hua keʻokeʻo ma o ka hoʻoheheʻe biochemical kuhikuhi me nā enzyme paʻakikī e hoʻohana ana i ka ʻenehana bioengineering hou. Loaʻa iā ia he 20 mau amino acids pono e koi ʻia e ke kino o ke kanaka, a ʻo kona ʻano hui ʻana ua kokoke i ka protein serum kanaka. [3]
ʻO ka maikaʻi o ka albumin peptide
▪ Ka palekana olakino a me ka hoʻoikaika ʻana i ka pale kino kino[4]
ʻO ka ʻōnaehana pale kino ka nui o nā ʻāpana pale, nā cell immune a me nā mea hana pale. ʻO nā pūnaewele kino nā pūnaewele e pāʻani ana i ka hana immune, e like me nā phagocytes a me nā lymphocytes. ʻO ka Ovalbumin peptide kahi peptide mole liʻiliʻi i maʻalahi i ka ʻōpū. Hiki iā ia ke hoʻoulu i ka hoʻonui ʻana o nā lymphocytes ponoʻī o ke kino, paipai i ka hoʻokuʻu ʻana o nā cytokines, hoʻonui i ka hiki phagocytosis o nā macrophages o ke kino, a hoʻoulu i ka macrophage phagocytosis ma nā haʻahaʻa haʻahaʻa. Hana hana: Ma ka hoʻoulu ʻana i ka hoʻonui nui ʻana o nā lymphocytes i nā ʻiole, hoʻonui i ka neʻe ʻana o nā lymphocytes i nā wahi ʻeha, a me ka hoʻoulu ʻana i nā lymphocytes e hūnā i nā lymphokines, e hoʻoikaika i ka hoʻonui ʻana i ka hana pale o ke kino.
Eia kekahi, ʻo Lillard et al. Ua hōʻike ʻia e hiki i nā peptides ovalbumin ke hoʻomaikaʻi i ka pale ʻana ma o ka paipai ʻana i ka hana ʻana o nā mea bioactive pili i ka pale.
▪ Hoʻonui i ka meaʻai kino [2][3]
Hiki i ka EAP (albumin peptide) ke hoʻoikaika i ka hoʻihoʻi ʻana i nā ʻulaʻula ʻulaʻula, hoʻomaikaʻi i ka hiki o ka lawe ʻana i ka oxygen o nā ʻulaʻula ʻulaʻula, mālama i ka synthesis protein maʻamau i loko o ke kino, a loaʻa iā ia ka pale nui o ka cell a me nā hopena anti-fatigue. Ua hōʻike nā haʻawina he hopena koʻikoʻi ko ka albumin peptide nutritional intervention i nā maʻi me ka hypoalbuminemia. .
Ka hopena
Ma ke ʻano he mea hāʻawi hoʻonā honua no nā peptides hana, loaʻa i ka PEPDOO nā mana e like me kahi papa hana hoʻomaʻemaʻe maʻemaʻe 100,000-level a me 5 palapala hōʻoia ʻōnaehana palekana palekana. ʻO kāna huahana makahiki o nā peptides ikaika a hiki i ka 6,000 tons, a iā ia ka ʻenehana R&D a me ka ʻenehana e hana i nā peptides albumin ma kahi nui. Hoʻopiha piha i nā hōʻailona hana. Kōkua ʻo PEPDOO® Albumin Peptide me ka meaʻai maikaʻi.
[1] 2023 National Health Insight Report-Ohana Ola Kauka Lilac 2023.06
[2] Liu Dan, Du Xianshi, Wen Wu, et al. Ka nānā ʻana i ka pono o ka albumin peptide nutritional intervention i nā maʻi me ka hypoalbuminemia [J]. ʻO ka male, hānau keiki a me ke olakino, 2021.
[3] No ka hoʻohana ʻana i nā mea inu albumin peptide i nā meaʻai hana ʻoihana noiʻi DOI: 10.16043/j.cnki.cfs.2021.17.013
[4] ʻO Chen Dongliang, Liu Li, Tang Liangyan, a me nā mea ʻē aʻe. Ka hopena hoʻoikaika kino o ka peptide ovalbumin ma nā ʻiole [J]. ʻEpekema Meaʻai a me ʻenehana, 2007, (01): 219-223.
